Can East-Meet-West medicine slow spine damage in ankylosing spondylitis?
NCT ID NCT07509775
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether combining traditional Chinese medicine with standard Western treatments can better control spine inflammation and slow damage in people with ankylosing spondylitis. About 210 adults aged 18-75 will be followed for up to two years. The goal is to see if this integrated approach reduces spinal swelling and prevents long-term harm.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANKYLOSING SPONDYLITIS (AS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
China-Japan Friendship Hospital
RECRUITINGBeijing, Beijing, China, 100029, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New app aims to ease depression and pain in ankylosing spondylitis patients
- Nerve block injection may ease back pain in ankylosing spondylitis patients
- Smartphone addiction may worsen neck problems in arthritis patients
- Blood sample study explores new target for inflammatory arthritis
- Ancient meets modern: can chinese medicine boost standard care for back pain?
- Large study tracks spine disease progression in thousands of chinese patients